_version_ 1785091101798957056
author Gavriatopoulou, Maria
Spencer, Andrew
Coriu, Daniel
Escalante Barrigón, Fernando
Hájek, Roman
Seguro, Fernanda
Gutiérrez, Norma C.
Basic Kinda, Sandra
Offidani, Massimo
Fantl, Dorotea Beatriz Eugenia
Bittencourt, Rosane
Lysén, Anna
Maisnar, Vladimir
Askari, Elham
Martinez-Lopez, Joaquín
Hughes, Olivia
Taylor, Rebekah
Lehn, Kristin
Joehanes, Roby
Ross, Jeremy
Hader, Carlos
author_facet Gavriatopoulou, Maria
Spencer, Andrew
Coriu, Daniel
Escalante Barrigón, Fernando
Hájek, Roman
Seguro, Fernanda
Gutiérrez, Norma C.
Basic Kinda, Sandra
Offidani, Massimo
Fantl, Dorotea Beatriz Eugenia
Bittencourt, Rosane
Lysén, Anna
Maisnar, Vladimir
Askari, Elham
Martinez-Lopez, Joaquín
Hughes, Olivia
Taylor, Rebekah
Lehn, Kristin
Joehanes, Roby
Ross, Jeremy
Hader, Carlos
author_sort Gavriatopoulou, Maria
collection PubMed
description
format Online
Article
Text
id pubmed-10431028
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104310282023-08-17 P832: PROSPECTIVE REAL-WORLD EVALUATION OF THE PREVALENCE OF T(11;14) IN MULTIPLE MYELOMA: THIRD INTERIM ANALYSIS FROM THE MEDICI STUDY Gavriatopoulou, Maria Spencer, Andrew Coriu, Daniel Escalante Barrigón, Fernando Hájek, Roman Seguro, Fernanda Gutiérrez, Norma C. Basic Kinda, Sandra Offidani, Massimo Fantl, Dorotea Beatriz Eugenia Bittencourt, Rosane Lysén, Anna Maisnar, Vladimir Askari, Elham Martinez-Lopez, Joaquín Hughes, Olivia Taylor, Rebekah Lehn, Kristin Joehanes, Roby Ross, Jeremy Hader, Carlos Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431028/ http://dx.doi.org/10.1097/01.HS9.0000970232.93818.10 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Gavriatopoulou, Maria
Spencer, Andrew
Coriu, Daniel
Escalante Barrigón, Fernando
Hájek, Roman
Seguro, Fernanda
Gutiérrez, Norma C.
Basic Kinda, Sandra
Offidani, Massimo
Fantl, Dorotea Beatriz Eugenia
Bittencourt, Rosane
Lysén, Anna
Maisnar, Vladimir
Askari, Elham
Martinez-Lopez, Joaquín
Hughes, Olivia
Taylor, Rebekah
Lehn, Kristin
Joehanes, Roby
Ross, Jeremy
Hader, Carlos
P832: PROSPECTIVE REAL-WORLD EVALUATION OF THE PREVALENCE OF T(11;14) IN MULTIPLE MYELOMA: THIRD INTERIM ANALYSIS FROM THE MEDICI STUDY
title P832: PROSPECTIVE REAL-WORLD EVALUATION OF THE PREVALENCE OF T(11;14) IN MULTIPLE MYELOMA: THIRD INTERIM ANALYSIS FROM THE MEDICI STUDY
title_full P832: PROSPECTIVE REAL-WORLD EVALUATION OF THE PREVALENCE OF T(11;14) IN MULTIPLE MYELOMA: THIRD INTERIM ANALYSIS FROM THE MEDICI STUDY
title_fullStr P832: PROSPECTIVE REAL-WORLD EVALUATION OF THE PREVALENCE OF T(11;14) IN MULTIPLE MYELOMA: THIRD INTERIM ANALYSIS FROM THE MEDICI STUDY
title_full_unstemmed P832: PROSPECTIVE REAL-WORLD EVALUATION OF THE PREVALENCE OF T(11;14) IN MULTIPLE MYELOMA: THIRD INTERIM ANALYSIS FROM THE MEDICI STUDY
title_short P832: PROSPECTIVE REAL-WORLD EVALUATION OF THE PREVALENCE OF T(11;14) IN MULTIPLE MYELOMA: THIRD INTERIM ANALYSIS FROM THE MEDICI STUDY
title_sort p832: prospective real-world evaluation of the prevalence of t(11;14) in multiple myeloma: third interim analysis from the medici study
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431028/
http://dx.doi.org/10.1097/01.HS9.0000970232.93818.10
work_keys_str_mv AT gavriatopouloumaria p832prospectiverealworldevaluationoftheprevalenceoft1114inmultiplemyelomathirdinterimanalysisfromthemedicistudy
AT spencerandrew p832prospectiverealworldevaluationoftheprevalenceoft1114inmultiplemyelomathirdinterimanalysisfromthemedicistudy
AT coriudaniel p832prospectiverealworldevaluationoftheprevalenceoft1114inmultiplemyelomathirdinterimanalysisfromthemedicistudy
AT escalantebarrigonfernando p832prospectiverealworldevaluationoftheprevalenceoft1114inmultiplemyelomathirdinterimanalysisfromthemedicistudy
AT hajekroman p832prospectiverealworldevaluationoftheprevalenceoft1114inmultiplemyelomathirdinterimanalysisfromthemedicistudy
AT segurofernanda p832prospectiverealworldevaluationoftheprevalenceoft1114inmultiplemyelomathirdinterimanalysisfromthemedicistudy
AT gutierreznormac p832prospectiverealworldevaluationoftheprevalenceoft1114inmultiplemyelomathirdinterimanalysisfromthemedicistudy
AT basickindasandra p832prospectiverealworldevaluationoftheprevalenceoft1114inmultiplemyelomathirdinterimanalysisfromthemedicistudy
AT offidanimassimo p832prospectiverealworldevaluationoftheprevalenceoft1114inmultiplemyelomathirdinterimanalysisfromthemedicistudy
AT fantldoroteabeatrizeugenia p832prospectiverealworldevaluationoftheprevalenceoft1114inmultiplemyelomathirdinterimanalysisfromthemedicistudy
AT bittencourtrosane p832prospectiverealworldevaluationoftheprevalenceoft1114inmultiplemyelomathirdinterimanalysisfromthemedicistudy
AT lysenanna p832prospectiverealworldevaluationoftheprevalenceoft1114inmultiplemyelomathirdinterimanalysisfromthemedicistudy
AT maisnarvladimir p832prospectiverealworldevaluationoftheprevalenceoft1114inmultiplemyelomathirdinterimanalysisfromthemedicistudy
AT askarielham p832prospectiverealworldevaluationoftheprevalenceoft1114inmultiplemyelomathirdinterimanalysisfromthemedicistudy
AT martinezlopezjoaquin p832prospectiverealworldevaluationoftheprevalenceoft1114inmultiplemyelomathirdinterimanalysisfromthemedicistudy
AT hughesolivia p832prospectiverealworldevaluationoftheprevalenceoft1114inmultiplemyelomathirdinterimanalysisfromthemedicistudy
AT taylorrebekah p832prospectiverealworldevaluationoftheprevalenceoft1114inmultiplemyelomathirdinterimanalysisfromthemedicistudy
AT lehnkristin p832prospectiverealworldevaluationoftheprevalenceoft1114inmultiplemyelomathirdinterimanalysisfromthemedicistudy
AT joehanesroby p832prospectiverealworldevaluationoftheprevalenceoft1114inmultiplemyelomathirdinterimanalysisfromthemedicistudy
AT rossjeremy p832prospectiverealworldevaluationoftheprevalenceoft1114inmultiplemyelomathirdinterimanalysisfromthemedicistudy
AT hadercarlos p832prospectiverealworldevaluationoftheprevalenceoft1114inmultiplemyelomathirdinterimanalysisfromthemedicistudy